Teva reports Q4 EPS $1.00, consensus 77c

Reports Q4 revenue $4.46B, consensus $4.01B. Richard Francis, Teva‘s president and CEO, said: “2023 has been a year of significant advances for Teva, a year in which we gained momentum on our Pivot to Growth strategy, and achieved strong growth on our key innovative brands, accelerated our late-stage pipeline assets, and brought our generics business back to growth.”